Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity

被引：2
|
作者：
Ceylan, Osman Melih [1 ]
Dikci, Seyhan [1 ]
Genc, Oguzhan [1 ]
Yilmaz, Turgut [1 ]
机构：
[1] Inonu Univ, Dept Ophthalmol, Malatya, Turkey
来源：
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA | 2016年 / 79卷 / 04期
关键词：
D O I：
10.5935/0004-2749.20160080
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [41] Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity
    Travassos, Antonio
    Teixeira, Susana
    Ferreira, Pinto
    Regadas, Isaura
    Travassos, Ana Sofia
    Esteves Esperancinha, Florindo
    Prieto, Isabel
    Pires, Graca
    Van Velze, Robert
    Valido, A.
    do Ceu Machado, Maria
    OPHTHALMIC SURGERY LASERS & IMAGING, 2007, 38 (03) : 233 - 237
  • [42] Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China
    Feng, Jing
    Qian, Jing
    Jiang, Yanrong
    Zhao, Mingwei
    Liang, Jianhong
    Yin, Hong
    Chen, Yi
    Yu, Wenzhen
    Li, Xiaoxin
    OPHTHALMOLOGY, 2017, 124 (03) : 408 - 409
  • [43] Comparing safety and efficacy of Bevacizumab, Ranibizumab and Ranibizumab biosimilar in Retinopathy of prematurity
    Maitra, Puja
    Jaju, Sujay
    Agrawal, Kushal U.
    Das, Abhishek
    Subramaniam, Prema
    Venkatapathy, Narendran
    Shah, Parag K.
    EYE, 2025,
  • [44] Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
    Raizada, Seemant
    Al Kandari, Jamal
    Al Foudari, Ahmad
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2011, 18 (02) : 196 - 197
  • [45] Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
    Ahmed, Ayesha E.
    Channa, Roomasa
    Durrani, Jibran
    Ali, Azam
    Ahmad, Khabir
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2010, 17 (03) : 264 - 267
  • [46] Non-Response and Recurrence of Retinopathy of Prematurity after Intravitreal Ranibizumab Treatment
    Wu, Wei-Chi
    Chuluunbat, Tsengelmaa
    Chan, R. V. Paul
    Lai, Chi-Chun
    OPHTHALMOLOGICA, 2016, 236 : 39 - 40
  • [47] Type 1 retinopathy of prematurity: time to regressionfollowing treatment with intravitreal bevacizumab
    Tehrani, Nasrin Najm
    Isaac, Maram
    Mireskandari, Kamiar
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [48] Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
    Chang, Yu-Shan
    Chen, Ying-Tin
    Lai, Tso-Ting
    Chou, Hung-Chieh
    Chen, Chien-Yi
    Hsieh, Wu-Shiun
    Yang, Chung-May
    Yeh, Po-Ting
    Tsao, Po-Nien
    PLOS ONE, 2019, 14 (10):
  • [49] Comparison of Intravitreal Bevacizumab and Ranibizumab Treatment for Diabetic Macular Edema
    Ozturk, Banu Turgut
    Kerimoglu, Hurkan
    Bozkurt, Banu
    Okudan, Suleyman
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 373 - 377
  • [50] Effect of Low-dose Intravitreal Bevacizumab and Ranibizumab on Regression and Late Reactivation in Retinopathy of Prematurity in the Treatment-Naive Eyes
    Zhang, Charles
    Reynolds, Andrew L.
    Beiter, Andrew
    Lillvis, John H.
    Reynolds, James D.
    OPHTHALMOLOGY RETINA, 2022, 6 (04): : 328 - 330
12345